- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT05102435
Translation and Validation of the Performance Oriented Mobility Assessment (Poma) Scale Into Urdu Version
Cross-cultural Translation and Validation of the Performance Oriented Mobility Assessment (Poma) Scale Into Urdu Version
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
Among older persons, age-related impairments cause loss of postural control and balance that result in pain, independency and disability. One of the most common geriatric syndromes and most serious health issue threatening the independency of older persons is fall. The impact of these fall-related injuries on older person, families and societies and its fruitful intervention has made this issue important worldwide. Approximately 28-35% of people aged 65 years and 32-42% of aged 70 years' experience falls annually and 10% suffer serious injury such as, fracture, severe head trauma and joint dislocation. The incidence rate of fall is higher in hospitalized and residents of nursing home. It rises from middle age and peaks in person above 80 years. The risk factors associated with falls are, lower extremity muscle weakness, gait or balance deficits, use of an assistive device, cognitive impairment, visual deficit, arthritis and impaired activities of daily living . Different scales and tests are used for risk factors for falls, balance and mobility such as Berg Balance Scale, Time up and go test and dynamic gait index and Fullerton Advanced Balance Scale. One of these scales Performance-Oriented Mobility Assessment (POMA) scale. POMA scale has acceptable reliability and validity as compared to FRT and TUG in elderly. The advantages of this scale are; applicability, low cost, easy to administer, no equipment is needed other than a standard chair and stopwatch, evaluates functional activities and assesses both balance (POMA-B) and gait components (POMA-G)Originally POMA scale was used to assess risk of fall in institutionalized populations but later on used as an assessment tool for mobility and determine effects of interventions.
The POMA has found to be widely used in patients who have dynamic and reactive balance deficits. It comprises 16 items (9 balance and 7 gait related). Total time taken for administration is approximately 10 minutes and total score is 28; 16 is balance and 12 is gait score. Some Items are scored dichotomously (can/cannot perform) and others are scored 0, 1 or 2 points for quality of performance. The higher scores show low fall risk and better balance while lower score predicts poorer balance and greater risk of fall. The score 19-24/28 indicates moderate risk for falling while score <19 indicates a "high" risk for falling.
Tipo di studio
Iscrizione (Effettivo)
Contatti e Sedi
Luoghi di studio
-
-
-
Rawalpindi, Pakistan, 46000
- Misbah Ghous
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Metodo di campionamento
Popolazione di studio
Descrizione
Inclusion Criteria:
- The sample will be assessed a cognition evaluation through the mini-mental test
- Any present or previous history of vertigo since last 6 months
Exclusion Criteria:
- Patients with any neurological disorder,
- previous orthopedic surgery within last 6 months,
- bedridden,
- wearing any prosthesis, and illiteracy.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Performance oriented mobility Assessment scale
Lasso di tempo: 1 time assessment of mobility and balance (approximately 10 minutes)
|
Performance oriented mobility Assessment scale is used to assess risk of fall in institutionalized populations but later on used as an assessment tool for mobility and balance assessment.
Total time taken for administration is approximately 10 minutes and total score is 28; 16 is balance and 12 is gait score
|
1 time assessment of mobility and balance (approximately 10 minutes)
|
Collaboratori e investigatori
Sponsor
Investigatori
- Investigatore principale: Misbah ghous, MS, Riphah International University Islamabad
Pubblicazioni e link utili
Pubblicazioni generali
- Yücel SD, Şahin F, Doğu B, Şahin T, Kuran B, Gürsakal S. Reliability and validity of the Turkish version of the Performance-Oriented Mobility Assessment I. European Review of Aging and Physical Activity. 2012 Oct;9(2):149-59.
- Schulein S, Pflugrad L, Petersen H, Lutz M, Volland-Schussel K, Gassmann KG. [German translation of the performance-oriented mobility assessment according to Tinetti]. Z Gerontol Geriatr. 2017 Aug;50(6):498-505. doi: 10.1007/s00391-016-1070-9. Epub 2016 Jun 16. German.
- Moulodi B, Azad A, Taghizadeh G, Roohi-Azizi M, Mohammadi P. Reliability and validity of persian version of performance-oriented mobility assessment (POMA) in Community-dwelling Iranian Older Adults: Psychometric Properties. Iranian Rehabilitation Journal. 2020;18(1):39-48.
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Altri numeri di identificazione dello studio
- REC/00964 Kiran
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .